Anna Rydén

4.3k total citations · 2 hit papers
80 papers, 3.1k citations indexed

About

Anna Rydén is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anna Rydén has authored 80 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 22 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Anna Rydén's work include Lung Cancer Treatments and Mutations (17 papers), Gastroesophageal reflux and treatments (13 papers) and Diabetes and associated disorders (12 papers). Anna Rydén is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Gastroesophageal reflux and treatments (13 papers) and Diabetes and associated disorders (12 papers). Anna Rydén collaborates with scholars based in Sweden, United States and United Kingdom. Anna Rydén's co-authors include Marianne Sullivan, Sindre Rolstad, John R. Adler, Charles Taft, Jan Karlsson, Lars Sjöström, Caterina Finizia, Mia Johansson, Lars‐Olof Persson and Jarl Torgerson and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Anna Rydén

77 papers receiving 3.0k citations

Hit Papers

Ten-year trends in health-related quality of life after s... 2007 2026 2013 2019 2007 2011 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study
    2007 636 citations Charles Taft, Anna Rydén et al. profile →
  2. Response Burden and Questionnaire Length: Is Shorter Better? A Review and Meta-analysis
    2011 584 citations Sindre Rolstad, John R. Adler et al. Value in Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Rydén Sweden 28 1.0k 548 522 479 401 80 3.1k
Ivan Barofsky United States 26 908 0.9× 535 1.0× 270 0.5× 465 1.0× 490 1.2× 62 3.5k
Karin Helweg‐Larsen Denmark 27 321 0.3× 781 1.4× 414 0.8× 245 0.5× 207 0.5× 113 4.0k
Zachary J. Ward United States 29 726 0.7× 357 0.7× 328 0.6× 651 1.4× 449 1.1× 74 4.4k
Noor Asi United States 25 1.1k 1.1× 323 0.6× 545 1.0× 278 0.6× 79 0.2× 35 4.3k
Irene D. Feurer United States 43 2.0k 2.0× 691 1.3× 836 1.6× 999 2.1× 68 0.2× 154 5.6k
Melvin Swanson United States 35 3.2k 3.1× 494 0.9× 282 0.5× 2.0k 4.3× 832 2.1× 106 6.4k
Lena Ring Sweden 26 346 0.3× 259 0.5× 326 0.6× 367 0.8× 97 0.2× 53 3.6k
Joan M. Skelly United States 30 576 0.6× 268 0.5× 202 0.4× 906 1.9× 84 0.2× 104 3.4k
Suzanne L. Dibble United States 43 735 0.7× 651 1.2× 882 1.7× 434 0.9× 137 0.3× 109 6.1k
Margaret L. Lawson Canada 34 571 0.6× 484 0.9× 206 0.4× 113 0.2× 119 0.3× 96 4.1k

Countries citing papers authored by Anna Rydén

Since Specialization
Citations

This map shows the geographic impact of Anna Rydén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rydén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rydén more than expected).

Fields of papers citing papers by Anna Rydén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rydén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rydén. The network helps show where Anna Rydén may publish in the future.

Co-authorship network of co-authors of Anna Rydén

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rydén. A scholar is included among the top collaborators of Anna Rydén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rydén. Anna Rydén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niklasson, Anna, et al.. (2022). Living with Heart Failure: Patient Experiences and Implications for Physical Activity and Daily Living. ESC Heart Failure. 9(2). 1206–1215. 17 indexed citations
2.
Martin, Mona L., et al.. (2021). How patients being treated for non-small cell lung cancer value treatment benefit despite side effects. Quality of Life Research. 31(1). 135–146. 3 indexed citations
3.
Leighl, Natasha B., Nina Karaseva, Kazuhiko Nakagawa, et al.. (2019). Patient-reported outcomes from FLAURA: Osimertinib versus erlotinib or gefitinib in patients with EGFR-mutated advanced non-small-cell lung cancer. European Journal of Cancer. 125. 49–57. 46 indexed citations
4.
Rydén, Anna, Fiona Blackhall, Hye Ryun Kim, et al.. (2017). Patient Experience of Symptoms and Side Effects when Treated with Osimertinib for Advanced Non-Small-Cell Lung Cancer: A Qualitative Interview Substudy. Patient. 10(5). 593–603. 9 indexed citations
5.
Du, Xin, Markus Karlsson, Yawei Xu, et al.. (2017). GW28-e0740 eHelp China, a randomised trial evaluating the effect of a smart phone-based patient support tool on treatment duration in patients prescribed rosuvastatin in China. Journal of the American College of Cardiology. 70(16). C27–C28. 1 indexed citations
6.
Lee, Chee Khoon, Silvia Novello, Anna Rydén, et al.. (2017). Patient-reported symptoms and impact of treatment with osimertinib vs chemotherapy for advanced non-small cell lung cancer. Annals of Oncology. 28. ii30–ii30. 1 indexed citations
7.
Rydén, Anna, Olivia C. Leavy, Katarina Halling, & Arthur A. Stone. (2016). Comparison of Daily versus Weekly Recording of Gastroesophageal Reflux Disease Symptoms in Patients with a Partial Response to Proton Pump Inhibitor Therapy. Value in Health. 19(6). 829–833. 6 indexed citations
8.
Vakil, Nimish, Anna Niklasson, Hans Denison, & Anna Rydén. (2014). Symptom profile in partial responders to a proton pump inhibitor compared with treatment-naïve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations. BMC Gastroenterology. 14(1). 177–177. 4 indexed citations
9.
Rydén, Anna, Hans Denison, Maria Karlsson, & Nimish Vakil. (2013). Development and validation of a patient-reported outcome instrument in partial responders to proton pump inhibitors. Scandinavian Journal of Gastroenterology. 48(9). 1018–1026. 8 indexed citations
10.
Chassany, Olivier, Nicholas J. Shaheen, Maria Karlsson, Nesta Hughes, & Anna Rydén. (2012). Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia. Scandinavian Journal of Gastroenterology. 47(12). 1412–1421. 10 indexed citations
11.
Johansson, Mia, Anna Rydén, & Caterina Finizia. (2011). Mental adjustment to cancer and its relation to anxiety, depression, HRQL and survival in patients with laryngeal cancer - A longitudinal study. BMC Cancer. 11(1). 283–283. 85 indexed citations
12.
Rolstad, Sindre, John R. Adler, & Anna Rydén. (2011). Response Burden and Questionnaire Length: Is Shorter Better? A Review and Meta-analysis. Value in Health. 14(8). 1101–1108. 584 indexed citations breakdown →
13.
14.
15.
16.
Persson, Lars‐Olof & Anna Rydén. (2006). Themes of effective coping in physical disability: an interview study of 26 persons who have learnt to live with their disability. Scandinavian Journal of Caring Sciences. 20(3). 355–363. 45 indexed citations
17.
Rydén, Anna & Jarl Torgerson. (2006). The Swedish Obese Subjects Study—what has been accomplished to date?. Surgery for Obesity and Related Diseases. 2(5). 549–560. 39 indexed citations
18.
Elfström, Magnus L., Anna Rydén, M Kreuter, Charles Taft, & Marianne Sullivan. (2004). RELATIONS BETWEEN COPING STRATEGIES AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SPINAL CORD LESION. Journal of Rehabilitation Medicine. 37(1). 9–16. 84 indexed citations
19.
Elfström, Magnus L., M Kreuter, Anna Rydén, Lo Persson, & Marianne Sullivan. (2002). Effects of coping on psychological outcome when controlling for background variables: a study of traumatically spinal cord lesioned persons. Spinal Cord. 40(8). 408–415. 54 indexed citations
20.
Montgomery, Hugh, et al.. (1996). Importance and attainment of life values among disabled and non-disabled people. Journal of Rehabilitation Medicine. 28(4). 233–240. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivan Barofsky Breakdown of academic impact, for papers by Karin Helweg‐Larsen Breakdown of academic impact, for papers by Zachary J. Ward Breakdown of academic impact, for papers by Noor Asi Breakdown of academic impact, for papers by Irene D. Feurer Breakdown of academic impact, for papers by Melvin Swanson Breakdown of academic impact, for papers by Lena Ring Breakdown of academic impact, for papers by Joan M. Skelly Breakdown of academic impact, for papers by Suzanne L. Dibble Breakdown of academic impact, for papers by Margaret L. Lawson
Rankless by CCL
2026